The company’s technology uses industrial carbon dioxide emissions, hydrogen and naturally occurring microbes to create high-grade proteins for human and animal consumption.
According to AgFunder News, NovoNutrients’ former CEO David Tze said in a LinkedIn post that the technology works and was being proven at the pilot phase. “The challenge was capital intensity in a shifting investment climate,” Tze said.
NovoNutrients also commenced the Assignment for the Benefit of Creditors process, a bankruptcy alternative that Tze said “opens a rare window to acquire proven gas fermentation technology with broad, multi-sector applications, issued patents, proprietary strains, and commercial-ready IP.”
The deadline for bids is July 31 at 5pm PT. Interested parties should contact Forrest Reineke at Armanino Advisory LLC.